Study Finds Potassium-Enhanced Salt Could Prevent Millions of Cardiovascular and Kidney Deaths Worldwide
Research published in Nature Health estimates that replacing part of sodium chloride with potassium chloride in table salt could avert up to four lakh deaths and 15 lakh cases of cardiovascular and kidney disease annually in India, and nearly thirty lakh deaths globally.
A study published in the journal Nature Health examined the health impact of potassium-enriched salt, which substitutes part of regular sodium chloride with potassium chloride. The researchers estimate that in India the switch could prevent about four lakh deaths and more than 15 lakh cases of cardiovascular and chronic kidney disease each year. Globally, the model projects nearly thirty lakh deaths and over one crore new cases could be avoided annually if all salt were replaced.
Bruce Neal, senior professorial fellow at The George Institute for Global Health, said the health gains would be widespread, potentially averting up to one in ten cardiovascular deaths in many countries. He noted that excessive sodium and insufficient potassium are established contributors to high blood pressure, a major risk factor for strokes, heart attacks and kidney disease.
The World Health Organization recommends lower-sodium salt substitutes that contain potassium as a cost-effective strategy to reduce non-communicable disease burden. The study modeled several scenarios, from a full global replacement to targeted use among people with diagnosed hypertension. Even limited adoption, such as switching only household table salt, was projected to prevent 18.5 lakh deaths and about 62 lakh disease cases; replacing salt in processed and restaurant foods alone could avert 15.6 lakh deaths and 54.6 lakh cases.
The authors wrote that worldwide replacement of all salt could prevent 2.96 million deaths, 10.17 million new cases and 69.43 million disability-adjusted life years each year from cardiovascular disease and chronic kidney disease. They acknowledged a potential risk of hyperkalaemia for individuals with advanced kidney disease, but said the overall benefits outweigh the risks. Nephrologist Vivek Jha, senior professorial fellow at The George Institute in India, emphasized that patients with serious kidney disease or on potassium-raising medications should receive education, proper labeling and clinical oversight to manage the risk.